| Financial Year |
March 31 2023 |
| Monetary Funds |
17,737,229.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
360,000.00 |
| Accounts Receivable |
245,641,228.60 |
| Advances to Suppliers |
20,684,530.17 |
| Other Receivables |
95,303,615.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
82,123,347.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
254,842,997.25 |
| Other Current Assets |
38,152,967.86 |
| Total Current Assets |
1,187,985,883.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
165,835,781.35 |
| Long-term Equity Investment |
367,743,643.41 |
| Investment Properties |
-- |
| Fixed Assetes |
41,095,194.35 |
| Under-construction Projects |
28,708,821.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,227,570.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
510,396.21 |
| Deferred Income Tax Assets |
7,422,769.54 |
| Other Non-Current Assets |
533,728,102.10 |
| Sub-Total of Non-Current Assets |
1,176,051,268.97 |
| Total Assets |
2,364,037,152.66 |
| Short-Term Loans |
245,792,982.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
777,947,545.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,144,626.90 |
| Taxes Payable |
61,360,316.68 |
| Interest Payable |
31,983,826.20 |
| Dividend Payable |
-- |
| Other payables |
110,354,378.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
320,859,642.51 |
| Other Current Liabilities |
66,731,641.40 |
| Sub-Total of Current Liabilities |
1,695,625,621.60 |
| Long-term Loans |
66,417,944.87 |
| Bonds Payable |
320,863,962.35 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
390,756,163.68 |
| Total Liabilities |
2,086,381,785.28 |
| Paid-In Capital(Or Share Stock) |
338,384,791.00 |
| Capital Surplus |
231,246,384.20 |
| Surplus Reserve |
61,261,935.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-374,244,546.39 |
| Minority Stockholder's Interest |
1,424,895.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
276,230,472.32 |
| Owner's Equity（Stockholder's Equity） |
277,655,367.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,364,037,152.66 |
